However, the relative importance of GrB in in vivo cytotoxicity by CTLs has been questioned [46], and, in some cases, GrB expression at the tumor site correlates to the severity of the disease, poor prognosis and resistance to therapy [45, 47–51]. Here, GZMB is linked to neoplasm.